An experimental Pfizer drug extended the lives of patients who had a disease in which clumps of protein break apart into toxic substances that damage the heart.
Category: NASDAQ:ALNY
Pfizer Drug Reduces Death Rate In Patients With Hearts Damaged By Protein Clumps
An experimental Pfizer drug extended the lives of patients who had a disease in which clumps of protein break apart into toxic substances that damage the heart.
Alnylam Prices First Gene Silencing Drug At $450,000 Per Patient, But Offers Money-Back Guarantee
This morning, after 16 years and $2.5 billion in investment, the Cambridge, Mass.-based company Alnylam finally turned a 1998 biology breakthrough into a medicine: a drug called Onpattro to treat the destruction of nerves that results from a rare disea…
